Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine (Q43873037)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2002
edit
Language Label Description Also known as
English
Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine
scientific article published in February 2002

    Statements

    Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine (English)
    Marcela V Karpuj
    Mark W Becher
    Joe E Springer
    Dorothee Chabas
    Sawsan Youssef
    Rosetta Pedotti
    Dennis Mitchell
    Lawrence Steinman
    1 February 2002
    143-149

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit